MARCH2, a T cell specific factor that restricts HIV-1 infection
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012330 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Supawadee Umthong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States…. Hauptthemen laut MEDLINE: HIV-1, Ubiquitin-Protein Ligases, HIV Infections, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Ministry of Higher Education, Science, Research and Innovation, Thailand.
Abstract (Originalsprache)
Membrane-associated RING-CH (MARCH) 2 is a member of the MARCH protein family of RING-CH finger E3 ubiquitin ligases that play important roles in regulating the levels of proteins found on the cell surface. MARCH1, 2 and 8 inhibit HIV-1 infection by preventing the incorporation of the envelope glycoproteins into nascent virions. However, a better understanding of the mechanism utilized by MARCH proteins to restrict HIV-1 infection is needed. In this report, we identify an amino acid in human MARCH2, absent in mouse MARCH2, critical for its antiretroviral function. Moreover, we map the domains of human MARCH2 critical for restricting as well as binding to the HIV-1 envelope glycoproteins. In addition, we demonstrate that MARCH2 is present inside nascent virions and reduces particle infectivity by blocking virus entry in a RING-CH-independent manner. Finally, we show that MARCH2 acts as an HIV-1 restriction factor only in primary CD4+ T cells and can prevent cell-to-cell transmission of HIV-1. Our findings reveal important new aspects of the antiviral mechanism utilized by human MARCH2 to restrict HIV-1 that have potential implications to all MARCH proteins with antiviral functions and their viral targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.
- Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Spyridon Stavrou
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Ministry of Higher Education, Science, Research and Innovation, Thailand
- Thailand Science Research and Innovation (TSRI) and Chulalongkorn University
Zitieren
APA
Umthong, S., Timilsina, U., D'Angelo, M. R., Salka, K., & Stavrou, S. (2024). MARCH2, a T cell specific factor that restricts HIV-1 infection. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012330
Vancouver
Umthong S, Timilsina U, D'Angelo MR, Salka K, Stavrou S. MARCH2, a T cell specific factor that restricts HIV-1 infection. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012330
BibTeX
@article{Umthong2024,
author = {Umthong, Supawadee and Timilsina, Uddhav and D'Angelo, Mary R and Salka, Kyle and Stavrou, Spyridon},
title = {MARCH2, a T cell specific factor that restricts HIV-1 infection},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012330}
}
EUVIMED